摘要
2013年1月15日以来,爱尔兰、英国、法国等多个欧洲国家相继发现本国部分市售牛肉产品中掺入马肉,且掺入的马肉还可能使用了食用马禁用的兽药"保泰松"。经欧盟有关组织和爱尔兰、英国、法国等相关部门联合调查后,将这起"马肉事件"定性为商业标识欺诈事件。文章对"马肉事件"始末及各国的调查溯源和应对处置结果进行概述,并总结相关经验和教训,以为我国预防和应对此类事件提供借鉴。
During January to March in 2013,a meat adulteration scandal,that beef products were found to contain undeclared horsemeat which may contain the veterinary drug banned for use in food-producing animals—phenylbutazone,has been revealed in some supermarkets of several European countries. After investigation,this incident was eventually defined as one of fraudulent labeling. This article gives an overview of the horsemeat scandal,as well as a discussion on the pros and cons of the responding procedures,thus to provide reference for us to cope with such kind of issues in China.
出处
《华南预防医学》
2013年第6期51-56,共6页
South China Journal of Preventive Medicine
基金
广东省食品安全卫生应急技术研究中心基金(粤科函社字[2011]733号)
关键词
马肉
保泰松
食品安全
Horsemeat
Phenylbutazone
Food safety
